中国糖尿病杂志
中國糖尿病雜誌
중국당뇨병잡지
CHINESE JOURNAL OF DIABETES
2008年
1期
40-41
,共2页
冯尤健%陈祥彪%刘桑燕%巫晓强%刘碧玲
馮尤健%陳祥彪%劉桑燕%巫曉彊%劉碧玲
풍우건%진상표%류상연%무효강%류벽령
糖尿病,2型%胰岛素强化治疗%胰岛β细胞
糖尿病,2型%胰島素彊化治療%胰島β細胞
당뇨병,2형%이도소강화치료%이도β세포
Pancreatic beta cell
新诊断2型糖尿病(T2DM)患者72例随机分为短期持续性皮下胰岛素泵(CSII)组及多次胰岛素皮下注射(MSII)组.结果 提示短期CSII及MSII治疗均可改善新诊断T2DM患者胰岛β细胞功能、减轻胰岛素抵抗;CSII较MSII效果好.其疗效与病程长短、治疗前血糖、胰岛素、C肽水平以及医师的技能有关.
新診斷2型糖尿病(T2DM)患者72例隨機分為短期持續性皮下胰島素泵(CSII)組及多次胰島素皮下註射(MSII)組.結果 提示短期CSII及MSII治療均可改善新診斷T2DM患者胰島β細胞功能、減輕胰島素牴抗;CSII較MSII效果好.其療效與病程長短、治療前血糖、胰島素、C肽水平以及醫師的技能有關.
신진단2형당뇨병(T2DM)환자72례수궤분위단기지속성피하이도소빙(CSII)조급다차이도소피하주사(MSII)조.결과 제시단기CSII급MSII치료균가개선신진단T2DM환자이도β세포공능、감경이도소저항;CSII교MSII효과호.기료효여병정장단、치료전혈당、이도소、C태수평이급의사적기능유관.
72 newly diagnosed type 2 diabetic patients were randomly divided into continuous subcutaneous insulin infusion(CSII)group and multiple subcutaneous insulin injection(MSII)group.The results showed that the short-term treatment of CSII and MSII could improve the β-cell function and lessen the insulin resistance in newly diagnosed type 2 diabetic patients,and CSII might be more effective.The effect was correlated to the course,levels of blood glucose,insulin,and C-peptide before treatment.
